[(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate

C15H21N3O7 — CID 156643650

IUPAC[(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate
SMILESC=CC[C@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](N=[N+]=[N-])[C@H]1OC(C)=O
InChIInChI=1S/C15H21N3O7/c1-5-6-11-14(23-9(3)20)13(17-18-16)15(24-10(4)21)12(25-11)7-22-8(2)19/h5,11-15H,1,6-7H2,2-4H3/t11-,12-,13-,14+,15+/m1/s1
InChIKeyOKDDFJDDVDKETJ-ZSAUSMIDSA-N
MW355.35 g/mol
LogP1.44
Rot. Bonds7

About [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate

[(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate (PubChem CID 156643650) has the molecular formula C15H21N3O7 and a molecular weight of 355.35 g/mol. Its IUPAC name is [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate.

Molecular Properties

Compound Name[(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate
PubChem CID156643650
Molecular FormulaC15H21N3O7
Molecular Weight355.35 g/mol
Exact Mass355.14
IUPAC Name[(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate
SMILESC=CC[C@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](N=[N+]=[N-])[C@H]1OC(C)=O
InChIInChI=1S/C15H21N3O7/c1-5-6-11-14(23-9(3)20)13(17-18-16)15(24-10(4)21)12(25-11)7-22-8(2)19/h5,11-15H,1,6-7H2,2-4H3/t11-,12-,13-,14+,15+/m1/s1
InChIKeyOKDDFJDDVDKETJ-ZSAUSMIDSA-N
XLogP1.44
TPSA136.89 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms25
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.35
LogP ≤ 51.44
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Azido_group', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

CID 15279667
CID 15279667
CID 102007728
CID 102007728
CID 123778252
CID 123778252
CID 144652900
CID 144652900
CID 153535080
CID 153535080
CID 156130866
CID 156130866
CID 156643704
CID 156643704
CID 166975571
CID 166975571
CID 166975613
CID 166975613
CID 170219381
CID 170219381
CID 170219424
CID 170219424
CID 174154698
CID 174154698

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate?
The IUPAC name of [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate (CID 156643650) is [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate.
What is the SMILES notation for [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate?
The canonical SMILES for [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate is C=CC[C@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](N=[N+]=[N-])[C@H]1OC(C)=O.
What is the InChIKey of [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate?
The InChIKey is OKDDFJDDVDKETJ-ZSAUSMIDSA-N. The full InChI is InChI=1S/C15H21N3O7/c1-5-6-11-14(23-9(3)20)13(17-18-16)15(24-10(4)21)12(25-11)7-22-8(2)19/h5,11-15H,1,6-7H2,2-4H3/t11-,12-,13-,14+,15+/m1/s1.
What are the key properties of [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate?
[(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate has a molecular weight of 355.35 g/mol, XLogP of 1.44, 7 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5R,6R)-3,5-diacetyloxy-4-azido-6-prop-2-enyloxan-2-yl]methyl acetate is sourced from PubChem (CID 156643650), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).